139 related articles for article (PubMed ID: 2141075)
21. Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography.
Decker MA; Zimmerman CL
J Chromatogr B Biomed Appl; 1995 May; 667(1):105-13. PubMed ID: 7663673
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and drug interactions of etretinate and acitretin.
Lambert WE; Meyer E; De Leenheer AP; De Bersaques J; Kint AH
J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S19-22. PubMed ID: 1460119
[TBL] [Abstract][Full Text] [Related]
23. Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670, etretin).
Brindley CJ
Dermatologica; 1989; 178(2):79-87. PubMed ID: 2522404
[TBL] [Abstract][Full Text] [Related]
24. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
Vahlquist A
Dermatologica; 1987; 175(5):224-8. PubMed ID: 2960573
[TBL] [Abstract][Full Text] [Related]
25. A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects.
Park HD; Kim HK; Chun MR; Kim JW; Kim DW; Lee JH; Huh WS; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):476-82. PubMed ID: 19640355
[TBL] [Abstract][Full Text] [Related]
26. Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
Bouvy ML; Sturkenboom MC; Cornel MC; De Jong-Van den Berg LT; Stricker BH; Wesseling H
Pharm Weekbl Sci; 1992 Apr; 14(2):33-7. PubMed ID: 1388261
[TBL] [Abstract][Full Text] [Related]
27. Acitretin. A review of its pharmacology and therapeutic use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 1377120
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. I. Acitretin.
Eisenhardt EU; Bickel MH
Drug Metab Dispos; 1994; 22(1):26-30. PubMed ID: 8149885
[TBL] [Abstract][Full Text] [Related]
29. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
Meffert H; Sönnichsen N
Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
[No Abstract] [Full Text] [Related]
30. Acitretin is converted to etretinate only during concomitant alcohol intake.
Grønhøj Larsen F; Steinkjer B; Jakobsen P; Hjorter A; Brockhoff PB; Nielsen-Kudsk F
Br J Dermatol; 2000 Dec; 143(6):1164-9. PubMed ID: 11122016
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
Kochhar DM; Penner JD; Minutella LM
Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
[TBL] [Abstract][Full Text] [Related]
32. Uptake of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, delivered to cultured human fibroblasts by serum proteins. Lack of evidence for perturbation of LDL catabolism.
Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
Biochim Biophys Acta; 1990 Nov; 1055(2):102-6. PubMed ID: 2146974
[TBL] [Abstract][Full Text] [Related]
33. Identification of etretinate metabolites in human bile.
Vane FM; Buggé CJ; Rodriguez LC
Drug Metab Dispos; 1989; 17(3):275-9. PubMed ID: 2568908
[TBL] [Abstract][Full Text] [Related]
34. Hepatic enzyme induction potential of acitretin in male and female Sprague-Dawley rats.
Small DS; McNamara PJ
J Pharm Sci; 1994 May; 83(5):662-7. PubMed ID: 8071817
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
Jakobsen P; Larsen FG; Larsen CG
J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
[No Abstract] [Full Text] [Related]
36. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F
J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
[TBL] [Abstract][Full Text] [Related]
38. Etretinate absorption in the in situ perfused intestinal lumen: preliminary studies in the rat.
Zimmerman CL; Johnson KE
Biopharm Drug Dispos; 1991; 12(1):49-57. PubMed ID: 1828179
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
[TBL] [Abstract][Full Text] [Related]
40. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
